<?xml version="1.0" encoding="UTF-8"?>
<p>Since he was confirmed to be infected with SARS‐CoV‐2, he was treated with intravenous immunoglobulin (5 g/d) for 2 days in the outpatient clinic. After the infusion ended, he was discharged to home isolation with active monitoring for clinical condition online by the local community health workers. He further received oral administration of antiviral agents (oseltamivir), empiric antibiotic (cefdinir) and Chinese traditional medicines (Lianhua Qingwen capsules) for 6 days at home. On the 3rd day of treatment (day 7 of illness, 25 January 2020), the patient's appetite remarkably improved and other encountered symptoms resolved, including myalgia, vomiting and chills. On the 5th day of treatment (day 9 of illness, 27 January 2020), his body temperature returned to normal, but he reported that dry cough remained unchanged and chest pain developed in his right lung when breathing deeply. Dry cough, dyspnoea and chest pain alleviated gradually and vanished 2 weeks later. This patient never reported any hemoptysis. As of 10 March 2020, this case was asymptomatic and bleeding events did not increase more than usual during the follow‐up period.</p>
